NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:
Intuit Inc., down $42.36 to $652.30.
Entities affiliated with Mailchimp co-founder Dan Kurzius priced a secondary offering of shares of the TurboTax maker below their previous closing price.
R.R. Donnelley & Sons Co., up 34 cents to $10.56.
Chatham Asset Management raised its offer to buy the communications company.
Moderna Inc., down $16.08 to $352.43.
The drug developer's CEO said current COVID-19 vaccines will likely be less effective against the omicron variant.
Lithia Motors Inc., up $7.69 to $291.33.
The auto dealership chain increased its stock buyback plan by $750 million.
Valero Energy Corp., down $1.23 to $66.94.
Crude oil and natural gas prices fell and weighed down energy stocks.
Bank of America Corp., down $1.12 to $44.47.
Bond yields fell significantly and weighed down banks, which rely on higher yields to charge more lucrative interest on loans.
TG Therapeutics Inc., down $8.16 to $15.20.
An FDA advisory committee will discuss a potential cancer treatment developed by the biopharmaceutical company.
Barnes & Noble Education Inc., down $1.86 to $7.02.
The operator of book stores on college campuses reported disappointing fiscal second-quarter financial results.
Before you consider TG Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TG Therapeutics wasn't on the list.
While TG Therapeutics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.